Aurora Sheboygan Prices – BCR/ABL1 Major Breakpoint Quantitative Test Costs $865

The BCR/ABL1 Major Breakpoint Quantitative Test is an advanced molecular diagnostic procedure primarily used for detecting and quantifying the BCR-ABL1 fusion gene, a critical marker in chronic myeloid leukemia (CML) and related leukemias. At Aurora Medical Center in Sheboygan County, this specialized test costs $865, reflecting the sophisticated laboratory technology and clinical expertise involved. The fee typically encompasses sample collection, RNA extraction, reverse transcription, quantitative PCR analysis, and result interpretation. Patients are advised to request a detailed, itemized estimate in advance to identify any additional costs (such as provider fees or follow-up consultations) and to confirm insurance coverage or out-of-pocket responsibilities.

Cost Breakdown

• Laboratory processing and analysis: Included in base price
• Sample collection (blood or bone marrow): Typically included, but verify with provider
• Clinical interpretation and report: Included
• Additional physician consultation: May be billed separately

Associated Costs to Consider

• Follow-up visits to discuss results
• Repeat testing for ongoing monitoring
• Additional blood or bone marrow tests if required
• Other diagnostic tests depending on your condition

Insurance & Payment Advice

• Check with your insurance provider if the test is covered under your plan, especially for cancer diagnostics.
• Request a pre-authorization if required by your insurer.
• Ask the hospital for an itemized estimate, including all associated fees.
• Inquire about payment plans or financial assistance if you are uninsured or underinsured.

Recovery & Preparation Tips

• No special preparation is usually needed for a blood draw; follow specific instructions if a bone marrow sample is required.
• Resume normal activities after the test unless otherwise instructed by your provider.
• Contact your provider if you experience any unusual symptoms after sample collection, such as persistent pain or swelling.

Frequently Asked Questions

• What is the BCR/ABL1 Major Breakpoint Quantitative Test used for?
  This test is primarily used to diagnose and monitor chronic myeloid leukemia (CML) by detecting the BCR-ABL1 fusion gene.
• Why does the test cost $865?
  The price reflects advanced laboratory technology, specialized genetic analysis, and expert interpretation required for accurate results.
• Is the cost of physician consultations included?
  The base test fee covers laboratory analysis and reporting; separate charges may apply for physician consultations or follow-up appointments.
• Will my insurance cover this test?
  Coverage varies by insurance plan; confirm with your provider and request pre-authorization if needed.
• Do I need to prepare for the test?
  Generally, no special preparation is needed for a blood test. Follow your provider’s instructions if a bone marrow sample is required.
• How long does it take to receive results?
  Results are typically available within several days to a week, but timing may vary by facility.
• Are there risks associated with the procedure?
  The blood draw is low-risk; bone marrow sampling may cause temporary discomfort or bruising.
• Can I request an itemized bill?
  Yes, always ask for an itemized estimate or bill to understand all charges and spot any potential errors.
• Will I need repeat testing?
  Ongoing monitoring for CML may require repeat testing; discuss the frequency with your healthcare provider.
• What happens if my test result is positive?
  Your healthcare provider will explain the implications and outline a treatment or monitoring plan tailored to your diagnosis.
• Who can I contact if I have questions about the cost?
  Contact the hospital billing department or your insurance provider for detailed information about costs and coverage.

The BCR/ABL1 Major Breakpoint Quantitative Test offered at Aurora Medical Center in Sheboygan County is a specialized diagnostic test used primarily to detect and quantify the presence of the BCR-ABL1 fusion gene, which is associated with certain types of leukemia, such as chronic myeloid leukemia (CML). This test is crucial for diagnosing, monitoring treatment response, and managing patients with CML. The cost of this test at Aurora Sheboygan is $865, reflecting the advanced technology and expertise required to perform this precise genetic analysis.

What is the BCR/ABL1 Major Breakpoint Quantitative Test? – The BCR/ABL1 Major Breakpoint Quantitative Test is a molecular diagnostic test that identifies and measures the BCR-ABL1 fusion gene, which is a key indicator of chronic myeloid leukemia (CML) and other leukemias.

Why is the BCR/ABL1 test important? – This test is crucial for diagnosing CML, monitoring the effectiveness of treatment, and adjusting therapeutic strategies based on the patient’s response.

How is the test performed? – The test is conducted by extracting RNA from a blood or bone marrow sample, followed by reverse transcription and quantitative polymerase chain reaction (qPCR) to detect the BCR-ABL1 fusion gene.

Who should undergo this test? – Patients suspected of having chronic myeloid leukemia or those undergoing treatment for CML are typically recommended to have this test to assess the presence and level of the BCR-ABL1 gene.

What does a positive result indicate? – A positive result indicates the presence of the BCR-ABL1 fusion gene, suggesting a diagnosis of chronic myeloid leukemia or another related leukemia.

How often should the test be repeated? – The frequency of testing depends on the treatment plan and the physician’s assessment, but it is often repeated regularly to monitor treatment response and disease progression.

Are there any risks associated with the test? – The test itself poses minimal risk, as it involves standard blood or bone marrow sampling procedures, which are generally safe.

How long does it take to get results? – Results are typically available within a few days to a week, depending on the laboratory’s processing time and workload.

Is the test covered by insurance? – Coverage for the test varies by insurance provider and plan, so patients should check with their insurance company to understand their specific coverage and out-of-pocket costs.